Vimarsana
Biggest News Aggregation in the World

Jonathana Bernstein News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jonathana Bernstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jonathana Bernstein Today - Breaking & Trending Today

Why One Nostril Gets More Clogged and Congested Than the Other - Vimarsana News

Why One Nostril Gets More Clogged and Congested Than the Other

A process called the nasal cycle causes one nostril to get more clogged than the other—and then it switches. Here's why it happens and how to clear congestion.

KalVista Pharmaceuticals Presents New Data at 2023 Meeting of the European Academy of Allergy and Clinical Immunology - Vimarsana News

KalVista Pharmaceuticals Presents New Data at 2023 Meeting of the European Academy of Allergy and Clinical Immunology

– Sebetralstat pharmacokinetic and pharmacodynamic data support globalization of the KONFIDENT phase 3 clinical trial and use in short-term prophylaxis – – Real-world patient data... | June 12, 2023

KalVista Pharmaceuticals, Inc.: KalVista Pharmaceuticals to Present Data at the 2023 American Academy of Allergy, Asthma & Immunology - Vimarsana News

KalVista Pharmaceuticals, Inc.: KalVista Pharmaceuticals to Present Data at the 2023 American Academy of Allergy, Asthma & Immunology

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today

KalVista Pharmaceuticals, Inc.: KalVista Pharmaceuticals to Present at the 2022 HAEi Global Leadership Workshop - Vimarsana News

KalVista Pharmaceuticals, Inc.: KalVista Pharmaceuticals to Present at the 2022 HAEi Global Leadership Workshop

Data provides patient perspectives on optimal treatment outcomes and quality-of-life challenges for people living with HAE - KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical

REACT Study: Allergy Therapy Improves Asthma Long Term - Vimarsana News

REACT Study: Allergy Therapy Improves Asthma Long Term

A large European cohort study reports that therapy for allergic rhinitis may enable people who also have asthma to use fewer asthma medications.